A New Hormone Replacement Paradigm: Physiologic Restoration Study
NCT04190927 is a phase 4 interventional trial sponsored by Women's Hormone Network. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Compounded topical estradiol and compounded topical progesterone in a carrier cream in Menopause, Menopause Related Conditions and 1 more condition. The registry lists an enrollment of 100 participants. The registry lists a start date of 1 Jun 2020 and a primary completion date of 1 Jun 2023.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04190927 |
| Status | Unknown |
| Phase | Phase 4 |
| Study type | Interventional trial |
| Lead sponsor | Women's Hormone Network |
| Enrollment | 100 |
| Conditions | Menopause, Menopause Related Conditions and Perimenopausal Disorder |
| Drugs | Compounded topical estradiol and compounded topical progesterone in a carrier cream |
| Start | 1 Jun 2020 |
| Primary completion | 1 Jun 2023 |
| Study completion | 1 Aug 2023 |
| Last update posted | 1 Apr 2020 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Julie Taguchi, MD
Principal Investigator
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT04190927
Each answer restates registry values shown on this page.
What is NCT04190927?
NCT04190927 is a phase 4 interventional trial sponsored by Women's Hormone Network. It studies Compounded topical estradiol and compounded topical progesterone in a carrier cream in Menopause, Menopause Related Conditions and 1 more condition.
Who leads NCT04190927?
The registry names Julie Taguchi, MD (principal investigator, Principal Investigator) as the overall official.
Which drugs does NCT04190927 study?
The registered drug and biological interventions are Compounded topical estradiol and compounded topical progesterone in a carrier cream.
When is NCT04190927 expected to complete?
The registry lists a primary completion date of 1 Jun 2023 and a study completion date of 1 Aug 2023. The sponsor last updated the record on 1 Apr 2020.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.